These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 18376226

  • 1. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
    Dizon DS, Restivo A, Lomme M, Charbonneau N, Brard L, Hughes T, Weitzen S, Legare R, Granai CO, Disilvestro P.
    Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226
    [Abstract] [Full Text] [Related]

  • 2. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study.
    Chan JK, Tian C, Fleming GF, Monk BJ, Herzog TJ, Kapp DS, Bell J.
    Gynecol Oncol; 2010 Mar; 116(3):301-6. PubMed ID: 19945740
    [Abstract] [Full Text] [Related]

  • 3. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE, Maxwell GL, Tian C, Sundborg MJ, Rose GS, Rose PG, Rubin SC, Muggia F, McGuire WP, Gynecologic Oncology Group.
    J Clin Oncol; 2008 Jan 01; 26(1):83-9. PubMed ID: 18025437
    [Abstract] [Full Text] [Related]

  • 4. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D, Fountzilas G, Aravantinos G, Kalofonos C, Efstathiou H, Farmakis D, Skarlos D, Pavlidis N, Economopoulos T, Dimopoulos MA.
    Gynecol Oncol; 2006 Aug 01; 102(2):285-91. PubMed ID: 16516283
    [Abstract] [Full Text] [Related]

  • 5. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T, Adolph A, Krepart GV, Lotocki R, Heywood MS.
    Gynecol Oncol; 2002 May 01; 85(2):351-5. PubMed ID: 11972399
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation].
    Gao KF, Liu FY, Chen FJ, Feng YL.
    Ai Zheng; 2007 Apr 01; 26(4):431-4. PubMed ID: 17430668
    [Abstract] [Full Text] [Related]

  • 7. Adjuvant platinum-based chemotherapy in patients with epithelial ovarian cancer: prognostic factors and final outcome.
    Grivas A, Lianos E, Internos I, Papaxoinis G, Tselepatiotis E, Ziras N, Athanasiou AE.
    J BUON; 2010 Apr 01; 15(4):647-51. PubMed ID: 21229624
    [Abstract] [Full Text] [Related]

  • 8. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S, EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm.
    J Natl Cancer Inst; 2003 Jan 15; 95(2):113-25. PubMed ID: 12529344
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC, Gynecologic Oncology Group.
    Cancer; 2008 May 15; 112(10):2202-10. PubMed ID: 18348296
    [Abstract] [Full Text] [Related]

  • 10. Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK, Tian C, Teoh D, Monk BJ, Herzog T, Kapp DS, Bell J.
    Gynecol Oncol; 2010 Mar 15; 116(3):307-11. PubMed ID: 19944452
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
    Le T, Alshaikh G, Hopkins L, Faught W, Fung MF.
    Ann Surg Oncol; 2006 Dec 15; 13(12):1711-6. PubMed ID: 17009146
    [Abstract] [Full Text] [Related]

  • 12. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease.
    Ho CM, Huang YJ, Chen TC, Huang SH, Liu FS, Chang Chien CC, Yu MH, Mao TL, Wang TY, Hsieh CY.
    Gynecol Oncol; 2004 Jul 15; 94(1):197-203. PubMed ID: 15262142
    [Abstract] [Full Text] [Related]

  • 13. A feasibility study of paclitaxel and carboplatin therapy in Japanese patients with epithelial ovarian cancer.
    Takei Y, Suzuki M, Ohwada M, Saga Y, Kohno T, Machida S, Sato I.
    Oncol Rep; 2003 Jul 15; 10(4):951-5. PubMed ID: 12792751
    [Abstract] [Full Text] [Related]

  • 14. Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients.
    Fader AN, von Gruenigen V, Gibbons H, Abushahin F, Starks D, Markman M, Belinson J, Rose P.
    Gynecol Oncol; 2008 Apr 15; 109(1):33-8. PubMed ID: 18261784
    [Abstract] [Full Text] [Related]

  • 15. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
    Zhao XD, Zhang Q, Zhang Y.
    Ai Zheng; 2005 Aug 15; 24(8):1002-5. PubMed ID: 16086882
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C, Greggi S, Tambaro R, Losito S, Iodice F, Di Maio M, Ferrari E, Falanga M, Formato R, Iaffaioli VR, Pignata S.
    Anticancer Res; 2005 Aug 15; 25(5):3501-5. PubMed ID: 16101169
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
    Dietrich CS, Modesitt SC, DePriest PD, Ueland FR, Wilder J, Reedy MB, Pavlik EJ, Kryscio R, Cibull M, Giesler J, Manahan K, Huh W, Cohn D, Powell M, Slomovitz B, Higgins RV, Merritt W, Hunter J, Puls L, Gehrig P, van Nagell JR.
    Gynecol Oncol; 2005 Dec 15; 99(3):557-63. PubMed ID: 16154185
    [Abstract] [Full Text] [Related]

  • 20. Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
    Bamias A, Papadimitriou C, Efstathiou E, Rodolakis A, Vlahos G, Voulgaris Z, Bozas G, Fountzilas G, Aravantinos G, Razis E, Gika D, Dimopoulos MA.
    BMC Cancer; 2006 Sep 25; 6():228. PubMed ID: 16999858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.